News & Updates
Filter by Specialty:
Biologic DMARDs offer clinical benefits in adult-onset Still disease
Use of biologic disease-modifying antirheumatic drugs (bDMARDs), particularly tocilizumab (TCZ), anakinra (ANK), and canakinumab (CNK), appears safe and effective in the treatment of adult-onset Still disease (AOSD), results of a systematic review and meta-analysis have shown.
Biologic DMARDs offer clinical benefits in adult-onset Still disease
15 May 2024
Perceptions of SLE flare differ between patients, physicians
Patients differ from physicians regarding their views of systemic lupus erythematosus (SLE) flares, a study has found. The former see flares as days of having fatigue, pain, and skin issues, while the latter define flares as periods of elevated clinical SLE activity.
Perceptions of SLE flare differ between patients, physicians
15 May 2024
Self-administered acupressure relieves pain in probable knee OA
A randomized controlled trial (RCT) among community-dwelling middle-aged and older adults shows that self-administered acupressure (SAA) can relieve knee pain in probable knee osteoarthritis (OA).
Self-administered acupressure relieves pain in probable knee OA
03 May 2024
Stair climbing difficulty tied to higher death risk in adults with knee OA
The risk of all-cause mortality appears to be elevated in adults with or at high risk for knee osteoarthritis (OR) who have difficulty climbing stairs or who seldom use the stairs.